Compositions and methods for inhibition of the JAK pathway

Details for Australian Patent Application No. 2010281404 (hide)

Owner RIGEL PHARMACEUTICALS, INC.

Inventors Taylor, Vanessa; Li, Hui; Singh, Rajinder

Agent Griffith Hack

Pub. Number AU-A-2010281404

PCT Pub. Number WO2011/017178

Priority 61/229,191 28.07.09 US

Filing date 28 July 2010

Wipo publication date 10 February 2011

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 27/14 (2006.01) Drugs for disorders of the senses

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/017178 Priority application(s): WO2011/017178

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010281408-System and method of testing high brightness LED (HBLED)

2010281403-Compositions and methods for treating Gaucher disease